| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 11/21/2001 | CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 11/21/2001 | CN1323218A The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
| 11/21/2001 | CN1323217A Methods for therapeutic vaccination |
| 11/21/2001 | CN1323201A Extended release buccal bioadhesive tablet |
| 11/21/2001 | CN1323198A Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 11/21/2001 | CN1322559A Externally applied sterility plaster |
| 11/21/2001 | CN1322542A Preparation of external-use medicine for mastoproliferation |
| 11/21/2001 | CN1322531A Balancing antiinflame agent |
| 11/21/2001 | CN1322526A Compound for treating female sexual dysfunction |
| 11/21/2001 | CN1322474A Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
| 11/21/2001 | CN1075069C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes |
| 11/20/2001 | US6319947 Vanadium (IV) metallocene complexes having spermicidal activity |
| 11/20/2001 | US6319938 Prophylactic or therapeutic drug for renal diseases |
| 11/20/2001 | US6319935 Used in treatment of elevated intraocular pressure, non insulin-dependent diabetes, male impotence and obesity |
| 11/20/2001 | US6319930 Substituted dimeric compounds |
| 11/20/2001 | US6319912 Administering daily dosage units of a progestational agent equal in progestational activity of levonogestrel, second phase of dosage of antiprogesin comprising benzisothiazoline derivative and third phase of placebo for contraception |
| 11/20/2001 | US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) |
| 11/20/2001 | US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer |
| 11/20/2001 | US6319192 Method for the treatment of fertility disorders |
| 11/20/2001 | CA2053864C Modified forms of reproductive hormones |
| 11/15/2001 | WO2001085942A2 Cytoskeleton-associated proteins |
| 11/15/2001 | WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 11/15/2001 | WO2001085783A2 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof |
| 11/15/2001 | WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 11/15/2001 | WO2001085677A1 Amino acid derivatives and their use as medicines |
| 11/15/2001 | WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | WO2001085197A1 Method for curing diffusive masthopaty |
| 11/15/2001 | WO2001085194A1 Method and composition for the treatment of angiogenesis |
| 11/15/2001 | WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 11/15/2001 | WO2001085149A2 Felbamate derived compounds |
| 11/15/2001 | WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF |
| 11/15/2001 | WO2001085144A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 11/15/2001 | WO2001055172A3 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN |
| 11/15/2001 | WO2001047498A3 Hydrogel-driven layered drug dosage form comprising sertraline |
| 11/15/2001 | WO2001040255A3 14,15-beta-methylene substituted androgens |
| 11/15/2001 | WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 11/15/2001 | WO2001017512A3 Combination preparation for initiation of oestrus |
| 11/15/2001 | WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 11/15/2001 | US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 11/15/2001 | US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production |
| 11/15/2001 | US20010041705 Heterocyclic carboxamides |
| 11/15/2001 | US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 11/15/2001 | US20010041697 Implanting in an animal an effective amount of melengestrol acetate and trenbolone acetate for increasing growth performance, suppressing estrus and preventing pregnancy in an animal prefererably heifer |
| 11/15/2001 | US20010041672 Luteinizing hormone releasing hormone analogs or a combination with antiestrogen which is selected from raloxifen, droloxifen, centchroman or derivatives, useful for treating endometrioses and myomas ( gynecological conditions) |
| 11/15/2001 | US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate |
| 11/15/2001 | US20010041189 Dipeptide containing glutamic acid |
| 11/15/2001 | DE10113328A1 New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate |
| 11/15/2001 | CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof |
| 11/15/2001 | CA2409759A1 Method and composition for the treatment of angiogenesis |
| 11/15/2001 | CA2409758A1 Novel multicyclic compounds and the use thereof |
| 11/15/2001 | CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof |
| 11/15/2001 | CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/15/2001 | CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 11/15/2001 | CA2407850A1 Cytoskeleton-associated proteins |
| 11/15/2001 | CA2407830A1 Amino acid derivatives and their use as medicines |
| 11/15/2001 | CA2407697A1 Felbamate derived compounds |
| 11/14/2001 | EP1153125A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 11/14/2001 | EP1153013A2 5-ht1f agonists |
| 11/14/2001 | EP1152768A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
| 11/14/2001 | EP1003537B1 Composition comprising propolis and at least an essential oil |
| 11/14/2001 | CN1322246A Restin and methods of use thereof |
| 11/14/2001 | CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 11/14/2001 | CN1322202A Quinazoline derivatives |
| 11/14/2001 | CN1322111A Natural tea for curing men's impotence and method for manufacturing the same |
| 11/14/2001 | CN1321500A Method for preventing and curing diseases by using kakonein preparation |
| 11/14/2001 | CN1321496A Tongru preparation for promoting lactation |
| 11/14/2001 | CN1321491A Medicine for curing male infertility and female sterility |
| 11/14/2001 | CN1321490A Chinese medicine for external application-longfenggao for curing infertility and its preparation method |
| 11/14/2001 | CN1321477A Yang-invigorating medicine and its preparation method |
| 11/14/2001 | CN1321473A Compound rehmannia tea and its preparation method |
| 11/14/2001 | CN1321464A Water soluble clomiphene preparation and its preparation method |
| 11/13/2001 | US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells |
| 11/13/2001 | US6316458 Method of enhancing insulin action |
| 11/13/2001 | US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 11/13/2001 | US6316438 Fused pyridopyridazine inhibitors of cGMP phosphodiesterase |
| 11/13/2001 | US6316431 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 11/13/2001 | US6316413 Peptide agonists of bradykinin B2 receptor |
| 11/13/2001 | US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 11/13/2001 | US6316199 Arginase II |
| 11/08/2001 | WO2001083782A2 Novel proteases |
| 11/08/2001 | WO2001083775A2 Proteases |
| 11/08/2001 | WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 11/08/2001 | WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 11/08/2001 | WO2001083486A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
| 11/08/2001 | WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 11/08/2001 | WO2001083483A1 (5R)-(METHYLAMINO)-5,6-DIHYDRO-4H-IMIDAZO[4,5,1-ij]QUINOLINE-2(1H)-THIONE |
| 11/08/2001 | WO2001083480A2 Dihydropyridine compounds and methods of use |
| 11/08/2001 | WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 11/08/2001 | WO2001083462A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments |
| 11/08/2001 | WO2001083454A1 Benzosuberonylpiperidine compounds as analgesics |
| 11/08/2001 | WO2001082968A1 Cell proliferation inhibitors |
| 11/08/2001 | WO2001082923A1 Estrogen receptor modulators |
| 11/08/2001 | WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 11/08/2001 | WO2001039777A8 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 11/08/2001 | WO2001037780A8 Urotensin-ii analogs |
| 11/08/2001 | WO2000074666A3 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |